30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Glenn Tilton

Insider profile

Currently holds positions in Abbott Laboratories, Phillips 66 and Abbvie Inc

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Abbott Laboratories Jan. 1, 2007 -
Independent Director Phillips 66 April 1, 2012 -
Lead Independent Director Abbvie Inc Jan. 2, 2013 -
Director United Airlines Holdings Inc Dec. 31, 2012 - June 12, 2013
Non-Executive Chairman of the Board United Airlines Holdings Inc Oct. 1, 2010 - Dec. 31, 2012
Independent Director Corning Inc Nov. 30, 2010 - April 26, 2012

Glenn Tilton's trades of Abbvie Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2018-06-29 2018-06-27 B Purchase
5,739 -34.8%
480.16
US$1,838,542
5,739 -34.8% 480.16 US$1,838,542
2012-06-01 2012-05-31 PlS Planned sale
91,875 +8.8%
282.22
US$2,286,606
91,875 +8.8% 282.22 US$2,286,606
2011-05-06 2011-05-05 S Sale
42,088 +40.5%
484.15
US$3,336,646
42,088 +40.5% 484.15 US$3,336,646
2007-02-05 2007-02-02 S Sale
2,835 -0.6%
44.26
US$125,477
2,835 -0.6% 44.26 US$125,477
2007-02-05 2007-02-01 S Sale
51,965 -10.3%
44.20
US$2,296,853
51,965 -10.3% 44.20 US$2,296,853
2006-10-12 2006-10-11 PlS Planned sale
6,055 -1.3%
30.80
US$186,494
6,055 -1.3% 30.80 US$186,494
2006-09-14 2006-09-14 PlS Planned sale
6,056 -1.2%
27.02
US$163,633
6,056 -1.2% 27.02 US$163,633